David A. Sallman, MD

Assistant Member
Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida

Dr. David Sallman is an Assistant Member of the Malignant Hematology Department at H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. His research interests focus on the development of novel, targeted therapeutic strategies for patients with myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML) based on the underlying mutational drivers of the disease. Specifically, Dr. Sallman is involved in the study of the genetic drivers of myeloid diseases in order to improve prognostication for patients and also to allow for more personalized treatment. He has published significantly on this topic in peer-reviewed journals including Leukemia and Haematologica and this work is the foundation of clinical trials/translational studies designed to improve the quality of life and survival of patients with MDS. Dr. Sallman is also the principal investigator on multiple on-going studies focused on higher risk MDS.

Last modified: March 3, 2020